SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-009773
Filing Date
2022-09-19
Accepted
2022-09-19 17:09:25
Documents
1
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 form4-09192022_020914.html 4  
1 form4-09192022_020914.xml 4 3719
  Complete submission text file 0001415889-22-009773.txt   5214
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709
Business Address
Velleca Mark A. (Reporting) CIK: 0001706847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221251278